belzutifan
merck
['belzutifan', 'rcc,(-irccs),(-srcc),(-urcc)']
 #esmo22 great talk &amp; promising data:no clinical practice implications but supporting further assessment of belzutifan + tki in mrcc.high proportion favorable risk, no g4-5 traes, high efficacy signal! 
Oncologist, Professor, clinical/translational research, Genitourinary Cancers, bladder, prostate, testis, Univ of Washington, Fred Hutch; views are mine